A Study to Evaluate the Efficacy and Safety of BIIB093 in Participants With Brain Contusion
Clinical trial NCT03954041 · TERMINATED
Trial details
- NCT number
- NCT03954041
- Sponsor
- Remedy Pharmaceuticals, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-06
- Primary completion
- 2023-06-27
- Enrollment
- 92
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.